| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00262-013-1426-6 |
| P698 | PubMed publication ID | 23640602 |
| P2093 | author name string | Xuan Wang | |
| Fang-Cheng Zhang | |||
| Hong-Yang Zhao | |||
| Xiao-Ling Lu | |||
| Xiao-Bing Jiang | |||
| P2860 | cites work | Adoptive immunotherapy for cancer: building on success | Q24546258 |
| Cancer regression in patients after transfer of genetically engineered lymphocytes | Q24654976 | ||
| Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes | Q24676216 | ||
| Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope | Q27334728 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| The three Es of cancer immunoediting | Q28251475 | ||
| Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma | Q33286242 | ||
| Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses | Q33298687 | ||
| Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10. | Q33744525 | ||
| EGFRvIII-targeted vaccination therapy of malignant glioma | Q33758459 | ||
| Antibody-cytokine fusion proteins for the therapy of cancer | Q34164685 | ||
| Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting. | Q34376314 | ||
| Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display | Q36837485 | ||
| The EGFRvIII variant in glioblastoma multiforme | Q37424448 | ||
| Applications of single-chain variable fragment antibodies in therapeutics and diagnostics | Q37449265 | ||
| Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs. | Q39353271 | ||
| Efficient recovery of the functional IP10-scFv fusion protein from inclusion bodies with an on-column refolding system | Q40380865 | ||
| The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis | Q40400996 | ||
| Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. | Q40455900 | ||
| Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen | Q41870799 | ||
| Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma | Q43525895 | ||
| Bystander elimination of antigen loss variants in established tumors | Q44775116 | ||
| Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model | Q46853464 | ||
| The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. | Q47384264 | ||
| Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma | Q48478595 | ||
| Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma | Q48706370 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1261-1272 | |
| P577 | publication date | 2013-05-03 | |
| P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
| P1476 | title | A novel recombinant protein of IP10-EGFRvIIIscFv and CD8(+) cytotoxic T lymphocytes synergistically inhibits the growth of implanted glioma in mice | |
| P478 | volume | 62 |
| Q38958467 | CRM197 in Combination With shRNA Interference of VCAM-1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells |
| Q38927887 | CXCL10/XCL1 fusokine elicits in vitro and in vivo chemotaxis |
| Q45931583 | CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. |
| Q91690187 | Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers |
| Q34152633 | Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model |
| Q91992301 | Identification of Key Genes in Thyroid Cancer Microenvironment |
Search more.